Your browser doesn't support javascript.
loading
Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis.
Connolly, L; Chatfield, S; Freeman, J; Salter, A; Amato, M P; Brichetto, G; Chataway, J; Chiaravalloti, N D; Cutter, G; DeLuca, J; Dalgas, U; Farrell, R; Feys, P; Filippi, M; Inglese, M; Meza, C; Moore, N B; Motl, R W; Rocca, M A; Sandroff, B M; Feinstein, A.
Afiliación
  • Connolly L; Faculty of Health, School of Health Professions, University of Plymouth, Devon, UK. Electronic address: Luke.connolly@plymouth.ac.uk.
  • Chatfield S; Faculty of Health, School of Health Professions, University of Plymouth, Devon, UK.
  • Freeman J; Faculty of Health, School of Health Professions, University of Plymouth, Devon, UK.
  • Salter A; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Amato MP; Department NEUROFARBA, Section Neurosciences, University of Florence, Largo Brambilla 3, 50134 Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
  • Brichetto G; Scientific Research Area, Italian Multiple Sclerosis Foundation (FISM), via Operai 40, 16149 Genoa, Italy; AISM Rehabilitation Service, Italian Multiple Sclerosis Society, Genoa, Italy.
  • Chataway J; Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, Queen Square Multiple Sclerosis Centre, University College London, London WC1B 5EH, UK; National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, London
  • Chiaravalloti ND; Kessler Foundation, 120 Eagle Rock Avenue, Suite 100, East Hanover, NJ 07936, USA; Department of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Cutter G; Department of Biostatistics, University of Alabama At Birmingham, Birmingham, USA.
  • DeLuca J; Kessler Foundation, 120 Eagle Rock Avenue, Suite 100, East Hanover, NJ 07936, USA; Department of Physical Medicine and Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Dalgas U; Exercise Biology, Department of Public Health, Aarhus University, Dalgas Avenue 4, 8000 Aarhus, Denmark.
  • Farrell R; Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, Queen Square Multiple Sclerosis Centre, University College London, London WC1B 5EH, UK; National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, London
  • Feys P; REVAL, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.
  • Filippi M; Neuroimaging Research Unit, Division of Neuroscience, IRCSS San Raffaele Scientific Institute, Milan, Italy; Neurology Unit, IRCSS San Raffaele Scientific Institute, Milan, Italy; Neurorehabilitation Unit, IRCSS San Raffaele Scientific Institute, Milan, Italy; Neurophysiology Unit, IRCSS San Raffael
  • Inglese M; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, and Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy; Ospedale Policlinico San Martino-IRCCS, Genoa, Italy.
  • Meza C; Department of Psychiatry, University of Toronto and Sunnybrook Health Sciences Centre, Toronto, ON M5R 3B6, Canada.
  • Moore NB; Kessler Foundation, 120 Eagle Rock Avenue, Suite 100, East Hanover, NJ 07936, USA.
  • Motl RW; Department of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, USA.
  • Rocca MA; Neuroimaging Research Unit, Division of Neuroscience, IRCSS San Raffaele Scientific Institute, Milan, Italy; Neurology Unit, IRCSS San Raffaele Scientific Institute, Milan, Italy; Neurophysiology Unit, IRCSS San Raffaele Scientific Institute, Milan, Italy.
  • Sandroff BM; Kessler Foundation, 120 Eagle Rock Avenue, Suite 100, East Hanover, NJ 07936, USA; Department of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, USA.
  • Feinstein A; Department of Psychiatry, University of Toronto and Sunnybrook Health Sciences Centre, Toronto, ON M5R 3B6, Canada.
Mult Scler Relat Disord ; 90: 105798, 2024 Oct.
Article en En | MEDLINE | ID: mdl-39213864
ABSTRACT

BACKGROUND:

Fatigue is common in people with multiple sclerosis (MS). Understanding the relationship between fatigue, physical and neurobehavioural factors is important to inform future research and practice. Few studies explore this explicitly in people with progressive MS (pwPMS).

OBJECTIVE:

To explore relationships between self-reported fatigue, physical and neurobehavioural measures in a large, international progressive MS sample of cognitively impaired people recruited to the CogEx trial.

METHODS:

Baseline assessments of fatigue (Modified Fatigue Impact Scale; MFIS), aerobic capacity (VO2peak), time in moderate-vigorous physical activity (MVPA; accelerometery over seven-days), walking performance (6-minute walk test; 6MWT), self-reported walking difficulty (MS Walking Scale; MSWS-12), anxiety and depression (Hospital Anxiety and Depression Scale; HADS and Beck Depression Inventory-II; BDI-II), and disease impact (MS Impact Scale-29, MSIS-29) were assessed. Participants were categorised as fatigued (MFISTotal >=38) or non-fatigued (MFISTotal ≤38). STATISTICAL

ANALYSIS:

Differences in individuals categorised as fatigued or non-fatigued were assessed (t-tests, chi square). Pearson's correlation and partial correlations (adjusted for EDSS score, country, sex, and depressive symptoms) determined associations with MFISTotal, MFISPhysical, MFISCognitive and MFISPsychosocial, and the other measures. Multivariable logistic regression evaluated the independent association of fatigue (categorised MFISTotal) with physical and neurobehavioural measures.

RESULTS:

The sample comprised 308 pwPMS (62 % female, 27 % primary progressive, 73 % secondary progressive), mean age 52.5 ± 7.2 yrs, median EDSS score 6.0 (4.5-6.5), mean MFISTotal 44.1 ± 17.1, with 67.2 % categorised as fatigued. Fatigued participants walked shorter distances (6MWT, p = 0.043), had worse MSWS-12 scores (p < 0.001), and lower average % in MVPA (p = 0.026). The magnitude of associations was mostly weak between MFISTotal and physical measures (r = 0.13 to 0.18), apart from the MSWS-12 where it was strong (r = 0.51). The magnitude of correlations were strong between the MFISTotal and neurobehavioural measures of anxiety (r = 0.56), depression (r = 0.59), and measures of disease impact (MSIS-physical r = 0.67; MSIS-mental r = 0.71). This pattern was broadly similar for the MSIF subscales. The multivariable model indicated a five-point increase in MSWS-12 was associated with a 14 % increase in the odds of being fatigued (OR [95 %CI] 1.14 [1.07-1.22], p < 0.0001)

CONCLUSION:

Management of fatigue should consider both physical and neurobehavioural factors, in cognitively impaired persons with progressive MS.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ansiedad / Esclerosis Múltiple Crónica Progresiva / Depresión / Fatiga Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Relat Disord Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ansiedad / Esclerosis Múltiple Crónica Progresiva / Depresión / Fatiga Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Relat Disord Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos